EVIDENCE FOR THE STABILITY AND CYTOCHROME-P450 SPECIFICITY OF THE PHENOBARBITAL-INDUCED REDUCTIVE HALOTHANE-CYTOCHROME-P450 COMPLEX FORMED IN RAT HEPATIC MICROSOMES

被引:13
作者
BAKER, MT
VASQUEZ, MT
CHIANG, CK
机构
[1] Department of Anesthesia, University of Iowa, Iowa City
关键词
D O I
10.1016/0006-2952(91)90171-Z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hypothesis that the reduced spectral halothane-cytochrome P450 complex formed in rat hepatic microsomes is a stable cytochrome P450 specific species was examined. Comparisons of the cytochrome P450 inducers, phenobarbital (PB), pregnenolone-16-alpha-carbonitrile (PCN) and beta-naphthoflavone (beta-NF) showed that PB was the most effective inducer of the halothane-cytochrome P450 complex and the cytochrome P450 which liberates the halothane metabolites, 2-chloro-1,1-difluoroethene (CDE) and 2-chloro-1,1,1-trifluoroethane (CTE). However, the ratio of CDE produced to quantity of complex was found to be reduced 70-77% in these microsomes. A large portion of total microsomal cytochrome P450 was destroyed upon halothane reduction (up to 39%), yet the complexed cytochrome P450, particularly in microsomes from PB-treated animals, was resistant to the irreversible inactivation mechanisms of halothane reduction. The effects of reductive halothane metabolism on subsequent warfarin metabolism showed that 7-hydroxywarfarin formation from either (R)- or (S)-warfarin in microsomes from PCN-treated, PB-treated or untreated rats was highly susceptible to irreversible inhibition. In microsomes from PB-treated, but not PCN or untreated rats, the formation of one warfarin metabolite, 4'-hydroxywarfarin from (R)-warfarin, could be shown to be increased when complex was eliminated by photodissociation. These results suggest that PB-B is preferentially bound as complex and resistant to inactivation because of complex stability, and that halothane reduction readily destroys the cytochrome P450 form, PB-C.
引用
收藏
页码:1691 / 1699
页数:9
相关论文
共 29 条
[1]   THE MECHANISM OF REDUCTIVE DEHALOGENATION OF HALOTHANE BY LIVER CYTOCHROME-P450 [J].
AHR, HJ ;
KING, LJ ;
NASTAINCZYK, W ;
ULLRICH, V .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (03) :383-390
[2]  
BAKER MT, 1983, DRUG METAB DISPOS, V11, P308
[3]   REDUCTIVE HALOTHANE METABOLITE FORMATION AND HALOTHANE BINDING IN RAT HEPATIC MICROSOMES [J].
BAKER, MT ;
VANDYKE, RA .
CHEMICO-BIOLOGICAL INTERACTIONS, 1984, 49 (1-2) :121-132
[4]   STABILIZATION OF THE REDUCED HALOCARBON CYTOCHROME-P-450 COMPLEX OF HALOTHANE BY N-ALKANES [J].
BAKER, MT ;
BATES, JN ;
VANDYKE, RA .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (07) :1029-1034
[5]   A SENSITIVE AND SPECIFIC STABLE ISOTOPE ASSAY FOR WARFARIN AND ITS METABOLITES [J].
BUSH, ED ;
LOW, LK ;
TRAGER, WF .
BIOMEDICAL MASS SPECTROMETRY, 1983, 10 (07) :395-398
[6]   HEPATOTOXICITY AND HALOTHANE METABOLISM IN AN ANIMAL-MODEL WITH APPLICATION FOR HUMAN TOXICITY [J].
COUSINS, MJ ;
SHARP, JH ;
GOURLAY, GK ;
ADAMS, JF ;
HAYNES, WD ;
WHITEHEAD, R .
ANAESTHESIA AND INTENSIVE CARE, 1979, 7 (01) :9-24
[7]  
DEGROOT H, 1983, HEPATOLOGY, V3, P601
[8]   SUICIDAL INACTIVATION OF MICROSOMAL CYTOCHROME-P-450 BY HALOTHANE UNDER HYPOXIC CONDITIONS [J].
DEGROOT, H ;
HARNISCH, U ;
NOLL, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 107 (03) :885-891
[9]   NEW WARFARIN METABOLITE - STRUCTURE AND FUNCTION [J].
FASCO, MJ ;
DYMERSKI, PP ;
WOS, JD ;
KAMINSKY, LS .
JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (10) :1054-1059
[10]   EVIDENCE FOR FUNCTIONAL AND STRUCTURAL MULTIPLICITY OF PREGNENOLONE-16-ALPHA-CARBONITRILE-INDUCIBLE CYTOCHROME-P-450 ISOZYMES IN RAT-LIVER MICROSOMES [J].
GRAVES, PE ;
KAMINSKY, LS ;
HALPERT, J .
BIOCHEMISTRY, 1987, 26 (13) :3887-3894